Profiel
Ming-Chou Lee formerly worked at Quest Diagnostics Infectious Disease, Inc., as Director-Molecular Research & Development, ArcherDX LLC, as Senior Director-Assay Development, PrimeraDx, Inc., as Vice President-Product Development, and Exagen, Inc., as Chief Technology Officer from 2021 to 2022.
Dr. Lee received his doctorate degree from The University of Alabama.
Eerdere bekende functies van Ming-Chou Lee
| Bedrijven | Functie | Einde |
|---|---|---|
| EXAGEN INC. | Hoofd Techniek/Wetenschap/O&O | 31-12-2022 |
Quest Diagnostics Infectious Disease, Inc.
Quest Diagnostics Infectious Disease, Inc. Miscellaneous Commercial ServicesCommercial Services Provides diagnostic services | Corporate Officer/Principal | - |
ArcherDX LLC
ArcherDX LLC Packaged SoftwareTechnology Services Develops software solutions for investigating cancer treatment | Corporate Officer/Principal | - |
PrimeraDx, Inc.
PrimeraDx, Inc. Medical SpecialtiesHealth Technology Develops and commercializes molecular diagnostics systems | Corporate Officer/Principal | - |
Opleiding van Ming-Chou Lee
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
PrimeraDx, Inc.
PrimeraDx, Inc. Medical SpecialtiesHealth Technology Develops and commercializes molecular diagnostics systems | Health Technology |
The University of Alabama
The University of Alabama Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quest Diagnostics Infectious Disease, Inc.
Quest Diagnostics Infectious Disease, Inc. Miscellaneous Commercial ServicesCommercial Services Provides diagnostic services | Commercial Services |
Exagen, Inc.
Exagen, Inc. Medical/Nursing ServicesHealth Services Operates as a commercial-stage diagnostics company | Health Services |
ArcherDX LLC
ArcherDX LLC Packaged SoftwareTechnology Services Develops software solutions for investigating cancer treatment | Technology Services |
















